公司資料
Intuitive 股價、新聞與催化劑
- 股票代碼:
- ISRG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Sunnyvale, California
股票表現
390.33 USD (-1.06%)
收盤價
最後更新: 2026年8月17日
142B USD
市值
股價為何變動
As of Aug 17, 2026, ISRG closed down 1.06% at $390.33. No new same-company headline was identified in the current news window.
公司概覽
Robotic-Assisted Surgery
Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base.
Da Vinci Platform
The da Vinci surgical system enables surgeons to perform procedures through small incisions using articulated instruments and high-definition visualization. Da Vinci 5 is the newest generation and expands computing, sensing and ergonomic capabilities.
Ion Endoluminal System
Ion is a robotic platform for minimally invasive lung biopsy. Its flexible catheter and navigation technology allow clinicians to reach small peripheral pulmonary nodules for tissue acquisition.
Procedure-Driven Business Model
System placements expand Intuitive’s installed base, while each procedure generates recurring instrument and accessory demand. Service contracts, training and clinical support deepen hospital relationships and reinforce platform adoption.
未來催化劑
- Intuitive Surgical is still a da Vinci story, with the market focused on procedure growth, da Vinci 5 rollout, and installed-base monetization. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。